By identifying a gene signature from the transcriptome of HCC patients functionally related to mitotic cell cycle regulation, Lin et al. demonstrated the sensitivity of HCC lines with mutant TP53 or wild-type CTNNB1 genes to taxanes using gene–drug association analysis. This evidence concerns the gene TP53 and hepatocellular carcinoma.